Literature DB >> 20172279

International grading scheme for acute cellular rejection in small-bowel transplantation: single-center experience.

P Ruiz1, H Takahashi, V Delacruz, E Island, G Selvaggi, S Nishida, J Moon, L Smith, T Asaoka, D Levi, A Tekin, A G Tzakis.   

Abstract

A standardized grading scheme for the assessment of acute cellular rejection (ACR) in small-intestine transplantation was proposed in 2003 at the Eighth International Small Intestinal Transplantation Symposium. We have implemented the current grading scheme for ACR in small-bowel transplantation since October 2003. The pathologic diagnoses of those small-intestine biopsy samples, including ACR grade and other supplementary findings were evaluated. A total of 3484 small intestine biopsy samples from 155 patients were available for evaluation in this study. Frequency of grades 0, indeterminate, 1, 2, and 3 acute cellular rejection was 33.9%, 49.1%, 12.6%, 3.7%, and 0.8%, respectively. Duration of ACR episode strongly correlated with grade of ACR episode (P < .001). Other supplementary findings included acute vascular rejection component, 2.2%; increase in lymphoplasmacytic infiltrate in lamina propria, 15.7%; mucosal fibrosis, 0.4%; and regenerative changes, 0.3%. Our data substantiate that this grading system is reliable and useful for clinical decision making in bowel transplantation. We suggest that an assessment and quantification of supplementary findings be considered a component of the International Pathology Grading Scheme.

Entities:  

Mesh:

Year:  2010        PMID: 20172279     DOI: 10.1016/j.transproceed.2009.12.026

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Intestine and multivisceral transplantation: current status and future directions.

Authors:  Chandrashekhar A Kubal; Richard S Mangus; A Joseph Tector
Journal:  Curr Gastroenterol Rep       Date:  2015-01

2.  Micronutrient deficiencies in pediatric and young adult intestinal transplant patients.

Authors:  Agozie C Ubesie; Conrad R Cole; Jaimie D Nathan; Greg M Tiao; Maria H Alonso; Adam G Mezoff; Carol J Henderson; Samuel A Kocoshis
Journal:  Pediatr Transplant       Date:  2013-08-06

3.  CD4+ T cells persist for years in the human small intestine and display a TH1 cytokine profile.

Authors:  Raquel Bartolomé-Casado; Ole J B Landsverk; Sudhir Kumar Chauhan; Frank Sætre; Kjersti Thorvaldsen Hagen; Sheraz Yaqub; Ole Øyen; Rune Horneland; Einar Martin Aandahl; Lars Aabakken; Espen S Bækkevold; Frode L Jahnsen
Journal:  Mucosal Immunol       Date:  2020-06-22       Impact factor: 7.313

4.  Antibody-secreting plasma cells persist for decades in human intestine.

Authors:  Ole J B Landsverk; Omri Snir; Raquel Bartolomé Casado; Lisa Richter; Jeff E Mold; Pedro Réu; Rune Horneland; Vemund Paulsen; Sheraz Yaqub; Einar Martin Aandahl; Ole M Øyen; Hildur Sif Thorarensen; Mehran Salehpour; Göran Possnert; Jonas Frisén; Ludvig M Sollid; Espen S Baekkevold; Frode L Jahnsen
Journal:  J Exp Med       Date:  2017-01-19       Impact factor: 14.307

5.  Transcriptional and functional profiling defines human small intestinal macrophage subsets.

Authors:  Anna Bujko; Nader Atlasy; Ole J B Landsverk; Lisa Richter; Sheraz Yaqub; Rune Horneland; Ole Øyen; Einar Martin Aandahl; Lars Aabakken; Hendrik G Stunnenberg; Espen S Bækkevold; Frode L Jahnsen
Journal:  J Exp Med       Date:  2017-12-22       Impact factor: 14.307

6.  Resident memory CD8 T cells persist for years in human small intestine.

Authors:  Raquel Bartolomé-Casado; Ole J B Landsverk; Sudhir Kumar Chauhan; Lisa Richter; Danh Phung; Victor Greiff; Louise F Risnes; Ying Yao; Ralf S Neumann; Sheraz Yaqub; Ole Øyen; Rune Horneland; Einar Martin Aandahl; Vemund Paulsen; Ludvig M Sollid; Shuo-Wang Qiao; Espen S Baekkevold; Frode L Jahnsen
Journal:  J Exp Med       Date:  2019-07-23       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.